Joseph de Rutte,
CEO and Co-Founder,
Partillion Bioscience
Dr. Joe de Rutte is the Co-Founder and CEO of Partillion Bioscience, a venture-backed startup that is commercializing the Nanovial technology he pioneered during his PhD at UCLA. This technology utilizes hydrogel microparticles to enable researchers to perform microfluidic assays without the need for new, complex instruments. The impact of his work has been recognized by leaders in the field, earning him the top Innovation Award at SLAS 2020 and the New Product Award in 2022. Since its inception, Dr. de Rutte has led Partillion, successfully raising venture capital funding and launching its first commercial products. These developments address a growing need for functional analysis of cells, showcasing the significant contributions of Dr. de Rutte and his team to the scientific community.
|
|
|
Add to Calendar ▼2024-11-18 00:00:002024-11-20 00:00:00Europe/LondonInnovations in Flow Cytometry and Extracellular Vesicles 2024Innovations in Flow Cytometry and Extracellular Vesicles 2024 in Laguna Hills, CaliforniaLaguna Hills, CaliforniaSELECTBIOenquiries@selectbiosciences.com
